systemic-lupus-erythematosus

Documents about systemic-lupus-erythematosus

• Efficacy of Vitamin C Supplementation on Malondialdehid Levels and Disease Activity in SLE Patients#905017ClinicalTrials.gov
• UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus#995229ClinicalTrials.gov
• Effects of Telehealth Initiative on Lupus Patients#846237ClinicalTrials.gov
• Care Coordination Approaches to Learning Lupus Self-management#879065ClinicalTrials.gov
• Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients#882493ClinicalTrials.gov
• Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)#887775ClinicalTrials.gov
• Urticarial hypocomplementemic vasculitis syndrome and systemic lupus erythematosus: a case report and review of the literature#291911HAL (France)
• Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients#296789Gestión del Repositorio Documental de la Universidad de Salamanca
• Chimeric antigen receptor T-cell therapy in systemic lupus erythematosus: From B cell depletion to immune reprogramming#780678Europe PMC
• A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)#845878ClinicalTrials.gov
• High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide#860755ClinicalTrials.gov
• Efficacy of Synbiotic Supplementation on IL-10, TGF-B and Disease Activity in Systemic Lupus Erythematosus Patients#916080ClinicalTrials.gov
• A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases#883392ClinicalTrials.gov
• Machine learning-based cardiovascular risk prediction in systemic lupus erythematosus: development and internal validation of a prognostic model#250288HAL (France)
• Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus#405217ClinicalTrials.gov
• Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients#1032264ClinicalTrials.gov
• Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis#864674ClinicalTrials.gov
• Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus#871312ClinicalTrials.gov
• Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus#889521ClinicalTrials.gov
• Efficacy of Seluang Fish Oil (Rasbora Argyrotaenia) and Synbiotics Supplementation on CD4+CD25+ Foxp3+ T-regulator Cells, IL17/IL-10 Ratio, and Disease Activity in Systemic Lupus Erythematosus Patients#800362ClinicalTrials.gov
• Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)#884244ClinicalTrials.gov
• Lessons from LUMINA: A multiethnic US cohort#277443Repositorio Universidad Peruana Cayetano Heredia
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)#829116ClinicalTrials.gov
• A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE#892994ClinicalTrials.gov
• The case for an Epstein-Barr virus vaccine: Lessons from its link to systemic lupus erythematosus#120197Europe PMC
• Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus#830032ClinicalTrials.gov
• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants#870271ClinicalTrials.gov
• Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)#181762ClinicalTrials.gov
• Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region#801026ClinicalTrials.gov
• Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus#883014ClinicalTrials.gov
• Triptorelin for Ovary Protection in Childhood Onset Lupus#896697ClinicalTrials.gov
• Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)#916527ClinicalTrials.gov
• A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)#842041ClinicalTrials.gov
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases#174961ClinicalTrials.gov
• Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU#1033491ClinicalTrials.gov
• REACT-01: Reversing Autoimmunity Through Cell Therapy#862740ClinicalTrials.gov
• Safety and Immunogenicity of a Zoster Vaccine in SLE#158033ClinicalTrials.gov
• Evaluation Of Serum MIF Level in SLE Patients#858465ClinicalTrials.gov
• Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus#865447ClinicalTrials.gov
• Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus#830180ClinicalTrials.gov
• Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE)#296595ClinicalTrials.gov
• BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115#812366ClinicalTrials.gov
• Effect of Green Tea on Treatment of Lupus#850183ClinicalTrials.gov
• Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune Diseases#800193ClinicalTrials.gov
• Omega 3 in LES and APS#414439ClinicalTrials.gov
• MB-CART19.1 in Refractory SLE#839427ClinicalTrials.gov
• A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus#901852ClinicalTrials.gov
• A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus#874602ClinicalTrials.gov
• Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic Techniques#887832ClinicalTrials.gov
• TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )#887451ClinicalTrials.gov